NCT00158561View on ClinicalTrials.gov

Chlorproguanil/Dapsone Compared With Chloroquine and SP for Vivax Malaria

PHASE3CompletedINTERVENTIONAL
Enrollment

750

Participants

Timeline

Start Date

February 29, 2004

Study Completion Date

March 31, 2006

Conditions
MalariaVivax Malaria
Interventions
DRUG

sulfadoxine-pyrimethamine and chlorproguanil-dapsone

Trial Locations (1)

Unknown

HealthNet International, Peshawar

Sponsors

Collaborators (1)

HealthNet TPO
All Listed Sponsors
collaborator

HealthNet TPO

OTHER

lead

London School of Hygiene and Tropical Medicine

OTHER